JP2016539641A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539641A5
JP2016539641A5 JP2016535065A JP2016535065A JP2016539641A5 JP 2016539641 A5 JP2016539641 A5 JP 2016539641A5 JP 2016535065 A JP2016535065 A JP 2016535065A JP 2016535065 A JP2016535065 A JP 2016535065A JP 2016539641 A5 JP2016539641 A5 JP 2016539641A5
Authority
JP
Japan
Prior art keywords
corneal endothelial
endothelial cells
laminin
composition according
culturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016535065A
Other languages
English (en)
Japanese (ja)
Other versions
JP6470286B2 (ja
JP2016539641A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2014/081917 external-priority patent/WO2015080297A1/en
Publication of JP2016539641A publication Critical patent/JP2016539641A/ja
Publication of JP2016539641A5 publication Critical patent/JP2016539641A5/ja
Application granted granted Critical
Publication of JP6470286B2 publication Critical patent/JP6470286B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016535065A 2013-11-27 2014-11-26 ラミニンの角膜内皮細胞培養への応用 Active JP6470286B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013244972 2013-11-27
JP2013244972 2013-11-27
PCT/JP2014/081917 WO2015080297A1 (en) 2013-11-27 2014-11-26 Application of laminin to corneal endothelial cell culture

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019006098A Division JP2019054828A (ja) 2013-11-27 2019-01-17 ラミニンの角膜内皮細胞培養への応用

Publications (3)

Publication Number Publication Date
JP2016539641A JP2016539641A (ja) 2016-12-22
JP2016539641A5 true JP2016539641A5 (cg-RX-API-DMAC7.html) 2017-12-07
JP6470286B2 JP6470286B2 (ja) 2019-02-13

Family

ID=52432880

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016535065A Active JP6470286B2 (ja) 2013-11-27 2014-11-26 ラミニンの角膜内皮細胞培養への応用
JP2019006098A Withdrawn JP2019054828A (ja) 2013-11-27 2019-01-17 ラミニンの角膜内皮細胞培養への応用
JP2020098407A Pending JP2020188778A (ja) 2013-11-27 2020-06-05 ラミニンの角膜内皮細胞培養への応用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019006098A Withdrawn JP2019054828A (ja) 2013-11-27 2019-01-17 ラミニンの角膜内皮細胞培養への応用
JP2020098407A Pending JP2020188778A (ja) 2013-11-27 2020-06-05 ラミニンの角膜内皮細胞培養への応用

Country Status (10)

Country Link
US (1) US11624053B2 (cg-RX-API-DMAC7.html)
EP (1) EP3074508B1 (cg-RX-API-DMAC7.html)
JP (3) JP6470286B2 (cg-RX-API-DMAC7.html)
CN (1) CN105814195A (cg-RX-API-DMAC7.html)
BR (1) BR112016011096A2 (cg-RX-API-DMAC7.html)
CA (1) CA2931280A1 (cg-RX-API-DMAC7.html)
ES (1) ES2763433T3 (cg-RX-API-DMAC7.html)
MX (1) MX2016006915A (cg-RX-API-DMAC7.html)
RU (1) RU2704984C1 (cg-RX-API-DMAC7.html)
WO (1) WO2015080297A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2788472T1 (sl) 2011-12-06 2019-04-30 Astellas Institute For Regenerative Medicine Način usmerjene diferencijacije, produciranja endotelijskih celic roženice
US11633477B2 (en) 2014-10-31 2023-04-25 Kyoto Prefectural Public University Corporation Treatment of cornea using laminin
EP3213761B1 (en) 2014-10-31 2021-05-19 Kyoto Prefectural Public University Corporation Novel treatment of retina using laminin
EP3375860A4 (en) * 2015-11-10 2019-07-03 Nikkiso Co., Ltd. CELL SUPPORT COMPOSITE AND METHOD FOR PRODUCING THE CELL SUPPORT COMPOSITE
JP6849957B2 (ja) * 2015-11-10 2021-03-31 国立大学法人京都大学 ラミニンフラグメント含有培地を用いる細胞培養方法
CA3052124C (en) * 2017-01-31 2024-06-25 Osaka University Method for controlling differentiation of pluripotent stem cells
WO2019079809A1 (en) * 2017-10-22 2019-04-25 The Johns Hopkins University BIOMIMETIC PLATFORMS FOR MODELING VASCULAR PHYSIOPATHOLOGY, DIAGNOSIS AND THERAPY
WO2019102593A1 (ja) * 2017-11-24 2019-05-31 株式会社Ihi 細胞培養装置
JP6664755B1 (ja) * 2018-10-02 2020-03-13 学校法人同志社 角膜内皮細胞を保存するための方法および容器
US11445723B2 (en) 2018-10-02 2022-09-20 The Doshisha Method and container for preserving corneal endothelial cells
CN113557059A (zh) * 2019-03-12 2021-10-26 日产化学株式会社 角膜疾病治疗剂
JP2023025311A (ja) * 2020-02-05 2023-02-22 味の素株式会社 タンパク質の製造方法
CN112522179A (zh) * 2020-12-23 2021-03-19 江苏艾尔康生物医药科技有限公司 一种角膜内皮细胞的分离培养方法

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678783B1 (en) 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
EP1195372A1 (en) 1994-04-18 2002-04-10 Mitsubishi Pharma Corporation N-heterocyclic substituted benzamide derivatives with antihypertensive activity
JP3421217B2 (ja) 1995-11-20 2003-06-30 麒麟麦酒株式会社 Ｒｈｏ標的タンパク質Ｒｈｏキナーゼ
AU3300297A (en) 1996-06-05 1998-01-07 General Hospital Corporation, The Laminin-5 and the formation of basement membrane structure
FR2765781B1 (fr) 1997-07-08 1999-09-24 Gioia Bruno Di Procede de fabrication d'un accessoire de mode, dispositif pour la mise en oeuvre du procede et accessoire de mode ainsi realise
US6042262A (en) 1997-07-29 2000-03-28 Stryker Technologies Corportion Apparatus for storing, mixing, and dispensing two-component bone cement
US6693169B1 (en) 1998-10-13 2004-02-17 The General Hospital Corporation Laminin 5, 13 and 14 and uses thereof
AU4675300A (en) 1999-04-30 2000-11-17 Biostatum, Inc. Recombinant laminin 5
US6635616B2 (en) 2000-05-01 2003-10-21 The General Hospital Corporation Laminin 15
US6933273B2 (en) 2000-12-21 2005-08-23 Karl Tryggvason Isolated laminin 10
ATE353889T1 (de) 2001-03-23 2007-03-15 Bayer Pharmaceuticals Corp Rho-kinase inhibitoren
WO2002076976A2 (en) 2001-03-23 2002-10-03 Bayer Corporation Rho-kinase inhibitors
CN101310771B (zh) 2001-04-11 2012-08-08 千寿制药株式会社 视觉功能障碍改善剂
JPWO2002100833A1 (ja) 2001-06-12 2004-09-24 住友製薬株式会社 Ｒｈｏキナーゼ阻害剤
CA2472619A1 (en) 2002-01-10 2003-07-24 Bayer Corporation Fused pyrimidine derivates as rho-kinase inhibitors
EP1470122B1 (en) 2002-01-23 2007-12-19 Bayer Pharmaceuticals Corporation Rho-kinase inhibitors
JP2004024852A (ja) 2002-04-30 2004-01-29 Amniotec:Kk 角膜内皮様シート、及びその作製方法
AU2003211971A1 (en) * 2002-04-30 2003-11-17 Amniotec Inc. Corneal endothelium-like sheet and method of constructing the same
CA2493230A1 (en) 2002-07-22 2004-01-29 Asahi Kasei Pharma Corporation 5-substituted isoquinoline derivative
CA2400996A1 (en) 2002-09-03 2004-03-03 Lisa Mckerracher 1,4-substituted cyclohexane derivatives
US7160894B2 (en) 2003-06-06 2007-01-09 Asahi Kasei Pharma Corporation Tricyclic compound
EP1644365A2 (en) 2003-07-02 2006-04-12 Biofocus Discovery Ltd Pyrazine and pyridine derivatives as rho kinase inhibitors
WO2005039564A1 (en) 2003-10-02 2005-05-06 Vertex Pharmaceuticals Incorporated Phthalimide compounds useful as protein kinase inhibitors
US7547779B2 (en) 2003-10-06 2009-06-16 Glaxo Group Limited Preparation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors
EP1670466A4 (en) 2003-10-06 2007-04-25 Glaxo Group Ltd PREPARATION OF 1,6,7-TRISUBSTITUTED AZABENIC ZIMIDAZOLES AS KINASE-INHIBITORS
WO2005037198A2 (en) 2003-10-06 2005-04-28 Glaxo Group Limited Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
WO2005038015A1 (en) 2003-10-10 2005-04-28 Cellular Bioengineering, Inc. Human corneal endothelial cells and methods of obtaining and culturing cells for corneal cell transplantation
CN100560142C (zh) 2003-10-10 2009-11-18 细胞生物工程公司 用于在生物聚合物上培养角膜内皮细胞和相关细胞以及产生人工角膜移植物的方法和组合物
EP1677848A2 (en) 2003-10-10 2006-07-12 Lui, Ge Ming Methods and compositions for growing corneal endothelial and related cells on biopolymers and creation of artifical corneal transplants
JP2007008816A (ja) 2003-10-15 2007-01-18 Ube Ind Ltd 新規イソキノリン誘導体
JP2007015928A (ja) 2003-10-15 2007-01-25 Ube Ind Ltd 新規オレフィン誘導体
TWI344961B (en) 2003-10-15 2011-07-11 Ube Industries Novel indazole derivative
EP4248752A3 (en) 2004-01-23 2024-01-03 President And Fellows Of Harvard College Improved modalities for the treatment of degenerative diseases of the retina
ES2532778T3 (es) 2004-02-12 2015-03-31 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Administración terapéutica del péptido antiangiogénico mezclado C16Y
JP2007523202A (ja) 2004-02-24 2007-08-16 ビオアクソン・テラプティーク・インコーポレーテッド ４置換ピペリジン誘導体
RU2006138621A (ru) 2004-04-02 2008-05-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Азаиндолы, полезные в качестве ингибиторов rock и других протеинкиназ
EP1829876A4 (en) 2004-11-26 2009-04-01 Asahi Kasei Pharma Corp NITROGENIC TRICYCLIC COMPOUND
CA2621181C (en) 2005-08-30 2011-04-19 Asahi Kasei Pharma Corporation 5-isoquinolinesulfonamide compounds
WO2007083685A1 (ja) 2006-01-19 2007-07-26 Senju Pharmaceutical Co., Ltd. 生体内で細胞増殖可能な角膜内皮製剤
US20090175835A1 (en) 2006-02-07 2009-07-09 Korea Institute Of Radiological & Medical Sciences Composition for treating damage of central or peripheral nerve system
WO2007127172A2 (en) 2006-04-27 2007-11-08 The Trustees Of Columbia University In The City Of New York Layered bio-adhesive compositions and uses thereof
US8951799B2 (en) 2007-01-04 2015-02-10 Biolamina Ab Composition and method for enabling proliferation of pluripotent stem cells
BRPI0816182A2 (pt) 2007-08-29 2015-04-14 Senju Pharma Co Agente para promoção de adesão celular endotelial corneana
US20090306772A1 (en) 2008-04-18 2009-12-10 The Regents Of The University Of California Ocular Scaffolds and Methods for Subretinal Repair of Bruch's Membrane
US8680182B2 (en) 2009-06-04 2014-03-25 Clemson University Research Foundation Methods for promoting the revascularization and reenervation of CNS lesions
WO2010140464A1 (ja) 2009-06-05 2010-12-09 国立大学法人 熊本大学 細胞の分化誘導方法
JP5590646B2 (ja) 2009-10-08 2014-09-17 国立大学法人大阪大学 ヒト多能性幹細胞用培養基材およびその利用
RU2418067C1 (ru) 2009-12-03 2011-05-10 Государственное образовательное учреждение высшего профессионального образования "Оренбургский государственный университет" Способ культивирования клеток
WO2011080984A1 (en) 2009-12-29 2011-07-07 Senju Pharmaceutical Co., Ltd. Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction
CA2828794C (en) 2010-12-17 2021-07-13 Biolamina Ab Cell culture medium
WO2012173207A1 (ja) 2011-06-14 2012-12-20 独立行政法人理化学研究所 網膜細胞への分化誘導方法
JP5761827B2 (ja) 2011-07-15 2015-08-12 国立大学法人大阪大学 角膜内皮細胞の調製方法
WO2013047763A1 (ja) 2011-09-29 2013-04-04 オリエンタル酵母工業株式会社 ラミニン５１１を含んだ系で哺乳類細胞を培養する方法
IL320536A (en) 2011-11-14 2025-06-01 Astellas Inst For Regenerative Medicine Pharmaceutical preparations of human RPE cells and their use
JP5985207B2 (ja) 2011-11-25 2016-09-06 住友化学株式会社 網膜色素上皮細胞の製造方法
CA2856867C (en) 2011-11-25 2021-06-01 Sumitomo Chemical Company, Limited Methods for producing retinal tissue and retina-related cell
SI2788472T1 (sl) * 2011-12-06 2019-04-30 Astellas Institute For Regenerative Medicine Način usmerjene diferencijacije, produciranja endotelijskih celic roženice
US9351914B2 (en) 2012-03-25 2016-05-31 The Board Of Trustees Of The Leland Stanford Junior University Methods for modulating hair growth using truncated laminin-511
RS57257B1 (sr) 2012-12-03 2018-08-31 Biolamina Ab Metodi proizvodnje rpe ćelija
JP6518879B2 (ja) 2013-10-09 2019-05-29 株式会社ヘリオス 網膜色素上皮細胞の純化方法
EP3213761B1 (en) 2014-10-31 2021-05-19 Kyoto Prefectural Public University Corporation Novel treatment of retina using laminin
US11633477B2 (en) 2014-10-31 2023-04-25 Kyoto Prefectural Public University Corporation Treatment of cornea using laminin
WO2020006539A1 (en) 2018-06-29 2020-01-02 Platelet Biogenesis, Inc. Compositions for drug delivery and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2016539641A5 (cg-RX-API-DMAC7.html)
RU2016125225A (ru) Применение ламинина в культуре клеток эндотелия роговицы
JP2014501518A5 (cg-RX-API-DMAC7.html)
WO2016083613A3 (en) Culture medium
EP4324913A3 (en) Culture media for stem cells
WO2012056110A3 (en) Cell culture material based on microbial cellulose
WO2011130624A3 (en) Sustained polypeptide expression from synthetic, modified rnas and uses thereof
EP3460042A4 (en) CELL CULTURE MEDIUM FOR ORGANOID CULTURE, CULTURE METHOD AND ORGANOID
WO2015188106A3 (en) Perfusion culturing methods and uses thereof
JP2016533322A5 (cg-RX-API-DMAC7.html)
EP3161127A4 (en) Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof
EP4234032A3 (en) Induction medium and methods for stem cell culture and therapy
WO2015158808A3 (en) Recombinant host cell engineered to overexpress helper proteins
WO2012062810A3 (en) Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor
JP2011004745A5 (cg-RX-API-DMAC7.html)
EP2543688A4 (en) Polymerization fluid, process for production thereof, transparent film made from the polymerization fluid, and transparent electrode
JP2016500260A5 (cg-RX-API-DMAC7.html)
HRP20210579T1 (hr) Cisteini protutijela s kapom i bez kape, te njihova upotreba u konjugiranju protutijela s lijekom
EP3511410A4 (en) MEDIUM FOR CULTIVATION OF STEM CELLS, METHOD FOR CULTURE OF STEM CELLS, PROMOTER OF STEM CELL GROWTH, AND CELL COMPOSITION AND METHOD FOR PRODUCING THE SAME
JP2012210156A5 (cg-RX-API-DMAC7.html)
WO2016106192A3 (en) Methods of culturing a mammalian cell
EP3162892A4 (en) Method for culturing adhesive cells, culture vessel, and method for producing protein
JP2014501620A5 (cg-RX-API-DMAC7.html)
EP4328299A3 (en) Cell culture media compositions for primary cells
MX380687B (es) Metodo para preparar células troncales con pluripotencia inducida a partir de células troncales mesenquimatosas utilizando una fracción de florotanino.